Dr Lal PathLabs to Acquire 70% Stake in SN Genelab for Up to ₹199.5 Crore
September 25, 2026
Dr Lal PathLabs Limited has approved the acquisition of a 70% stake in SN Genelab Private Limited (SN Gene), a diagnostics company focused on genomics services. The decision was approved…